UK cost agency backs melanoma drugs after price cuts 
November 2nd, 2012
LONDON | Thu Nov 1, 2012 8:01pm EDT LONDON (Reuters) – Two new drugs for skin cancer have been recommended for use on Britain’s state-run health service after the rival manufacturers – Roche and Bristol-Myers Squibb – agreed to cut their prices. The move underscores the growing pressure on drug companies to cut deals with austerity-hit European governments in order to prove their expensive new medicines offer value for money.
[Continue Reading...]
Republican candidate calls aborting rapist’s child "more violence on woman’s body"
November 1st, 2012
By Jonathan Kaminsky OLYMPIA, Washington | Thu Nov 1, 2012 12:42am EDT OLYMPIA, Washington (Reuters) – Tea Party politician John Koster, the Republican nominee for a hotly contested congressional seat in Washington state, says he opposes abortions, even in cases of “the rape thing,” because it is tantamount to inflicting “more violence onto a woman’s body.” The Snohomish County councilman made the comments during a weekend fundraising appearance in the Puget Sound city of Everett, north of Seattle, that was captured in a recording released on Wednesday by the liberal activist group Fuse Washington. Long known as an opponent of abortion, even in cases of rape or incest, Koster was asked if there were any circumstances under which he would approve of terminating a pregnancy. “When a mother’s life is in danger ..
[Continue Reading...]
Analysis: Employees to face healthcare sticker shock
October 28th, 2012
By Caroline Humer NEW YORK | Sun Oct 28, 2012 1:46pm EDT NEW YORK (Reuters) – Visit to New York City orthopedist: $223. One X-ray: $50. One follow-up magnetic resonance imaging test: $766.
[Continue Reading...]
FDA approves Teva leukemia drug
October 26th, 2012
Fri Oct 26, 2012 11:51am EDT (Reuters) – The U.S.
[Continue Reading...]
Novo confident in heart safety of new insulin
October 26th, 2012
By Mette Fraende and Ole Mikkelsen COPENHAGEN | Fri Oct 26, 2012 7:23am EDT COPENHAGEN (Reuters) – Novo Nordisk said it was confident about the safety of new ultra long-acting insulin degludec, after news a U.S. panel is to examine its heart risks sent the Danish group’s shares lower
[Continue Reading...]
U.S. probes deaths for links to Monster energy drink
October 23rd, 2012
Two cans of Monster Energy drink are pictured in this photo-illustration shot in Los Angeles October 22,2012. Credit: Reuters/Fred Prouser By Martinne Geller and David Morgan NEW YORK/WASHINGTON | Mon Oct 22, 2012 8:37pm EDT NEW YORK/WASHINGTON (Reuters) – The Food and Drug Administration said on Monday that it was investigating reports of five deaths that may be associated with Monster Beverage Corp’s namesake energy drink, and the company’s shares fell more than 14 percent.
[Continue Reading...]
Epilepsy drug leads to weight loss, side effects
October 17th, 2012
By Genevra Pittman NEW YORK | Wed Oct 17, 2012 5:00pm EDT NEW YORK (Reuters Health) – A drug approved to prevent seizures may also help obese people lose a few pounds when it’s added to therapy and nutritional guidance, a new small trial suggests. But people who took zonisamide also reported more side effects, from nausea and vomiting to anxiety and depression.
[Continue Reading...]
Analysis links psoriasis, diabetes
October 17th, 2012
By Genevra Pittman NEW YORK | Wed Oct 17, 2012 3:36pm EDT NEW YORK (Reuters Health) – A new review of more than two dozen studies adds support to the link between the chronic skin disease psoriasis and diabetes. In studies from the United States, Europe, the Middle East and elsewhere, participants with psoriasis had anywhere from an equal risk to an almost four-fold higher risk of developing diabetes than those without the skin condition
[Continue Reading...]
FDA warns Avon to smooth out claims on skin care products
October 17th, 2012
Tue Oct 16, 2012 8:34pm EDT (Reuters) – The U.S. Food and Drug Administration warned beauty products company Avon Products Inc to stop advertising its Anew range of skin care products using language that makes them sound like drugs
[Continue Reading...]
Indoor tanning still common in Germany
October 15th, 2012
By Frederik Joelving NEW YORK | Mon Oct 15, 2012 4:55pm EDT NEW YORK (Reuters Health) – Four in ten Germans ages 14 to 45 say they have tried indoor tanning and one in seven are current users, according to a survey out today. Germany enacted legislation banning minors from tanning salons in 2009.
[Continue Reading...]
